Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
2021 · New England Journal of Medicine · 884 citations
https://doi.org/10.1056/nejmoa2034975
A
Arnaud Bourdin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
783
Papers
15.6K
Citations
61
h-index
226
i10-index
Arnaud Bourdin is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Asthma and respiratory diseases & Respiratory and Cough-Related Research & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 61, co-authored 666 publications.
ORCID: 0000-0002-4645-5209Papers by this author
worksEosinophilic and Noneosinophilic Asthma
2021 · CHEST Journal · 243 citations
https://doi.org/10.1016/j.chest.2021.04.013
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
2014 · European Respiratory Journal · 170 citations
https://doi.org/10.1183/09031936.00014614
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years
2021 · The Journal of Allergy and Clinical Immunology In Practice · 126 citations
https://doi.org/10.1016/j.jaip.2021.07.058
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
2023 · JAMA · 103 citations
https://doi.org/10.1001/jama.2023.5355
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
2025 · The Lancet Respiratory Medicine · 56 citations
https://doi.org/10.1016/s2213-2600(24)00362-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat